The Galleri® Community Research Program
← catalyst calendarSponsored by GRAIL, Inc. (industry) · GRAL — their whole pipeline →.
Phase
—
Status
Enrolling by invitation
Study type
Observational
Enrollment
250estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-08-19 | actual | When the study began enrolling |
| Primary completion | Dec 2025 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2025 | estimated | The whole study's end, after follow-up |
| First posted | 2024-09-19 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-09-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Data Collection
Primary outcome
what the primary-completion date above is the date OFQuality of data retrieved from participants who have received the Galleri test
measured From enrollment to the the end of study (12 month study participation period), data will be retrieved and assessed for this measure.
Permalink · GRAL's whole pipeline · Catalyst calendar · Every registered study · What changed